Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression

Rodolphe Thiébaut123 Charlotte Charpentier4 Florence Damond4 Audrey Taieb1 Romain Antoine4 Jacqueline Capeau56 Geneviève Chêne123 Gilles Collin4 Sophie Matheron7 Diane Descamps4 Françoise Brun-Vézinet4 and for the French ANRS HIV-2 CO5 Cohort

首页> 外文期刊>Clinical Infectious Diseases >Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression

【24h】

Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression

机译：可溶性CD14和炎性生物标志物与HIV-2疾病进展的关系

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background. Human immunodeficiency virus type 2 (HIV-2) infection is characterized by a slower progression than HIV type 1. It is not known whether markers of inflammation such as high-sensitivity C-reactive protein (hsCRP), interleukin 6 (IL-6), and soluble CD14 (sCD14) may predict disease progression among HIV-2 patients.

机译：背景。人类2型免疫缺陷病毒（HIV-2）感染的特征是其发展速度慢于1型艾滋病毒。目前尚不清楚炎症标志物，例如高敏C反应蛋白（hsCRP），白介素6（IL-6）和可溶性CD14（sCD14）可以预测HIV-2患者的疾病进展。

著录项

来源
《Clinical Infectious Diseases》 |2012年第10期|p.1417-1425|共9页
作者
Rodolphe Thiébaut123 Charlotte Charpentier4 Florence Damond4 Audrey Taieb1 Romain Antoine4 Jacqueline Capeau56 Geneviève Chêne123 Gilles Collin4 Sophie Matheron7 Diane Descamps4 Françoise Brun-Vézinet4 and for the French ANRS HIV-2 CO5 Cohort;
展开▼
作者单位

1Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Santé Publique, d'Epidémiologie et de Développement (ISPED), Centre INSERM U897-Epidemiologie-Biostatistique 2Université Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique 3Centre Hospitalo-Universitaire de Bordeaux, Unité de Soutien Méthodologique à la Recherche Clinique et Epidémiologique, Bordeaux 4Laboratoire de Virologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Bichat-Claude Bernard, Hôpitaux Universitaires Paris Nord Val de Seine (HUPNVS), Université Paris Diderot 5INSERM U 938 6UPMC Univ Paris 06, UMR_S938 7Service des Maladies Infectieuses et Tropicales, AP-HP, Groupe Hospitalier Bichat-Claude Bernard, HUPNVS, Université Paris Diderot, Paris, France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression [J] . Thiebaut Rodolphe, Charpentier Charlotte, Damond Florence, Clinical infectious diseases . 2012,第10期

机译：可溶性CD14和炎性生物标志物与HIV-2疾病进展的关系
2. Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression [J] . Thiebaut Rodolphe, Charpentier Charlotte, Damond Florence, Clinical infectious diseases . 2012,第10期

机译：可溶性CD14和炎症生物标志物与HIV-2疾病进展的关联
3. Sepsis Markers Soluble IL-2 Receptor and Soluble CD14 Subtype as Potential Biomarkers for Complete Mucosal Healing in Patients With Inflammatory Bowel Disease [J] . Hosomi Shuhei, Yamagami Hirokazu, Itani Shigehiro, Journal of Crohn’s & colitis . 2018,第1期

机译：SEPSIS标记可溶性IL-2受体和可溶性CD14亚型作为炎症性肠病患者完全粘膜愈合的潜在生物标志物
4. Biomarker Discovery of CD14, A Soluble Endotoxin Receptor for Diagnosis of Stable Coronary Artery Disease [C] . Thomas S.-H. Chiou, Min-Yi Lee, Chao-Jen Kuo, ASMS Conference on Mass Spectrometry and Allied Topics . 2014

机译：生物标志物发现CD14，一种用于诊断稳定冠状动脉疾病的可溶内毒素受体
5. Targeting cyclophilin-CD147 interaction as an approach to treat inflammatory diseases [D] . Gill, Mandeep Kaur 2009

机译：靶向亲环蛋白-CD147相互作用作为一种治疗炎症性疾病的方法
6. Expression regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases [O] . Veronica Marcos, Phillip Latzin, Andreas Hector, 2010

机译：可溶性和膜CD14受体在小儿炎性肺疾病中的表达调控及临床意义
7. Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression [O] . R. Thiebaut, C. Charpentier, F. Damond, 2012

机译：可溶性CD14和炎症生物标志物与HIV-2疾病进展的缔合

Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression

摘要

著录项

相似文献

相关主题

期刊订阅